|
PDS5A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.762800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.772100E-02 |
| Normal-vs-Stage2 |
2.994600E-01 |
| Normal-vs-Stage3 |
5.430000E-04 |
| Normal-vs-Stage4 |
2.347800E-02 |
| Stage1-vs-Stage2 |
8.301600E-01 |
| Stage1-vs-Stage3 |
5.623800E-02 |
| Stage1-vs-Stage4 |
5.187800E-01 |
| Stage2-vs-Stage3 |
2.095600E-01 |
| Stage2-vs-Stage4 |
5.578800E-01 |
| Stage3-vs-Stage4 |
3.585800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.007620E-02 |
| Normal-vs-AfricanAmerican |
2.090499999996E-06 |
| Normal-vs-Asian |
6.317400E-01 |
| Caucasian-vs-AfricanAmerican |
8.837500E-04 |
| Caucasian-vs-Asian |
2.702600E-01 |
| AfricanAmerican-vs-Asian |
8.156700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.102500E-03 |
| Normal-vs-Female |
6.061600E-03 |
| Male-vs-Female |
7.082400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.294310E-02 |
| Normal-vs-Age(41-60Yrs) |
5.595800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.744500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.610100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.643200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.305200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.937000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.119500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.115350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.554400E-01 |
| Normal-vs-Grade 2 |
1.175400E-01 |
| Normal-vs-Grade 3 |
1.004920E-03 |
| Normal-vs-Grade 4 |
2.301500E-03 |
| Grade 1-vs-Grade 2 |
4.682000E-01 |
| Grade 1-vs-Grade 3 |
7.533800E-02 |
| Grade 1-vs-Grade 4 |
8.667600E-02 |
| Grade 2-vs-Grade 3 |
4.668000E-02 |
| Grade 2-vs-Grade 4 |
7.339700E-02 |
| Grade 3-vs-Grade 4 |
5.423200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.971800E-01 |
| Normal-vs-ccB subtype |
5.982000E-03 |
| ccA subtype-vs-ccB subtype |
3.345700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.580440E-02 |
| Normal-vs-N1 |
4.612000E-01 |
| N0-vs-N1 |
8.499600E-01 |
|
|
